Ipilimumab
MCC-17057
Unknown small_molecule completed
Quick answer
Ipilimumab for Metastatic Melanoma is a Unknown program (small_molecule) at Iovance Biotherapeutics B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Iovance Biotherapeutics B.V.
- Indication
- Metastatic Melanoma
- Phase
- Unknown
- Modality
- small_molecule
- Status
- completed